FDA To Expand Role Of Scientific Advisory Board
This article was originally published in The Pink Sheet Daily
Panel will have a broader charge to look at how the agency's scientific efforts support its regulatory mission.
You may also be interested in...
Among solutions suggested is six-year fixed term for the FDA commissioner and appointment of external advisory board to oversee cultural changes.
Singapore-based institute is also looking at dengue fever and malaria, exec says in interview with “The Pink Sheet” DAILY.
Lilly will pay up to $500 million to settle the "vast majority" of claims alleging that the company failed to adequately warn patients of risks associated with the atypical antipsychotic Zyprexa (olanzapine), the firm announced Jan. 4